An Open, Non Comparative Study of Ofloxacin I.V.
on the Treatment of Acute Symptomatic Urinary Tract
Infection
KORNTONG ASV ANICH, M.D.*,
SOMBOON SRIMUANG, M.D.**,
VICHAI FUGPHOLNGAM, M.D.*,
DEJA T ANPHAICHITRA, M.D.***
Affiliation : * Department of Family Medicine,
** Research Center,
*** Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
AbstractThe clinical efficacy and the safety of ofloxacin LV. in 35 acute symptomatic urinary tract
patients were evaluated. The drug was intravenously administered, 400 mg starting dose then
200 mg once-daily for 3-5 days. The therapeutic success rate and eradication rate in UTI case
were 100 per cent in all cases when evaluated immediately after completion of drug treatment,
therapeutic success rate and eradication rate at the follow-up evaluation were 97.2 per cent and
91.6 per cent respectively. Also, 5 cases of acute bronchitis and 2 salmonellosis were also
administered intravenously, 400 mg once-daily dose and 400 mg twice daily dose respectively.
No serious side effects of ofloxacin LV. therapy were observed in any of our patients.
Keywords : Ofloxacin, UTI, Bronchitis, Salmonellosis
All Articles
Download
